Follicular lymphoma grade IIIa, in remission is a subtype of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. This condition is clinically significant as it indicates a stage of the disease where the patient has responded to treatment, leading to remission. Accurate coding with ICD-10 Code C82.3A is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track treatment outcomes and resource utilization effectively.
ICD-10 Code C82.3A specifically denotes Follicular lymphoma grade IIIa, in remission, which is a more aggressive form of follicular lymphoma. This code should be used when documenting patients who have achieved remission following treatment, reflecting the current status of their disease. It is crucial for accurate clinical documentation and billing, ensuring that healthcare providers can appropriately categorize the patient's condition and treatment history.
Follicular lymphoma grade IIIa, in remission, is a hematological malignancy arising from B-lymphocytes, characterized by a higher proliferation rate compared to lower grades of follicular lymphoma. This condition requires careful monitoring and management due to its potential for transformation into a more aggressive form. Medical attention is necessary to ensure ongoing remission and to manage any potential complications.
ICD-10 Code C82.3A is utilized in SOAP notes to document the patient's current status of Follicular lymphoma grade IIIa, in remission. This code aids in capturing the patient's symptoms, assessment findings, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C82.3A connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Follicular lymphoma grade IIIa, in remission. This coding ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Management of Follicular lymphoma grade IIIa, in remission focuses on monitoring and supportive care to maintain remission and prevent relapse.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C82.3A is critical in medical billing, particularly in oncology and hematology settings, to accurately reflect the patient's diagnosis and treatment status.
| CPT Code | Description |
|---|---|
| 99214 | Established patient office visit, moderate complexity |
| 36415 | Collection of venous blood by venipuncture |
| 85025 | Complete blood count with automated differential |
| 88305 | Pathology examination of tissue, surgical pathology, gross and microscopic examination |
Common Questions About Using ICD-10 Code C82.3A for Follicular lymphoma grade IIIa, in remission
What does it mean if a patient is in remission?
Being in remission means that the signs and symptoms of Follicular lymphoma grade IIIa have significantly decreased or disappeared following treatment. This status indicates a positive response to therapy but requires ongoing monitoring for potential relapse.
How often should follow-up appointments occur for patients in remission?
Patients in remission from Follicular lymphoma grade IIIa should typically have follow-up appointments every 3 to 6 months. These visits are crucial for monitoring the patient's health and detecting any signs of relapse early.
Is Follicular lymphoma grade IIIa contagious?
No, Follicular lymphoma grade IIIa is not contagious. It is a type of cancer that arises from the body's own immune cells and cannot be transmitted from one person to another.
What are the common treatments for Follicular lymphoma grade IIIa?
Common treatments for Follicular lymphoma grade IIIa include chemotherapy, immunotherapy, and targeted therapy. The specific treatment plan depends on the patient's overall health and the extent of the disease.
Clinical Notes
SOAP notes
DAP notes
AI medical notes